Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Orthopedic Footwear Market size was over USD 4.37 billion in 2024 and is projected to reach USD 15.45 billion by 2037, witnessing around 10.2% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of orthopedic footwear is evaluated at USD 5.11 billion.
The major driving growth factors for this market are is increasing population with chronic diseases and pain. Orthopedic shoes are specially designed for people with deformities in the foot and ankle. They help to provide support to muscles and joints and help reduce pain while walking or standing. According to our research, at least one in four older people is affected by foot pain around the world.
In addition, the increased interest in participating in physical activities like walking, jogging, and playing sports is anticipated to open up a lot of chances for orthopedic footwear market expansion in the years to come. The World Health Organization (WHO) recommends that persons between the ages of 18 and 64 engage in at least 150–300 minutes of moderate-intensity or 75–150 minutes of vigorous-intensity aerobic physical activity each week
Orthopedic Footwear Sector: Growth Drivers and Challenges
Growth Drivers
- Increasing Health awareness and Popularity of Orthopedic Footwear- There has been growing awareness amongst the population about foot care and rising consumer spending on healthcare products. Owing to the various features associated with orthopedic footwear such as removable insole, extra width, and supportive heel, could be a factor projected to propel the growth of this orthopedic footwear market.
- Increasing Injuries- Increasing sports injuries, fractures, neuromuscular problems, and disorders are increasing the growth of this market. Fall injuries accounted for 51 % of medical care and 61% of emergency orthopedic surgery cases.
- Increasing Patients of Plantar Fasciitis- The global market is expected to grow as a result of the increased incidence of plantar fasciitis. People dealing with plantar fasciitis require extra cushioning in their footwear in order to provide support to their feet. Thus, orthopedic footwear is also opted by people for managing plantar fasciitis. According to a report published in the year 2022 by NCBI, in the United States, between 25 and 65 years of age, 83% of patients with plantar fasciitis are working adults.
Challenges
- Lack of Skilled Labor- Despite improving the orthopedic footwear market, there is a lack of necessary equipment as well as a lack of skilled labor in research and development. This is estimated to restrain the growth of the market in the forecasted period.
- High Cost Associated with the Orthopedic footwear
- Alternative treatments for Orthopedic Condition
Orthopedic Footwear Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
10.2% |
|
Base Year Market Size (2024) |
USD 4.37 billion |
|
Forecast Year Market Size (2037) |
USD 15.45 billion |
|
Regional Scope |
|
Orthopedic Footwear Segmentation
Product (Slippers, Sandals, Shoes)
The shoes segment is estimated to hold 45% share of the global orthopedic footwear market by the end of 2037. Orthopedic shoes are used to provide support to flat feet. In addition, there are numerous benefits of orthopedic shoes such as shock absorption, stability, and high ability to walk as well as distributing weight evenly, this segment is predicted to grow in the market during the forecasted period.
Indication (Diabetes & Edema, Arthritis, Flat Feet, Heel Pain)
The diabetes & edema segment in the orthopedic footwear market is set to garner the highest gain in the upcoming years with 47%. This segment is said to be increasing the market growth owing to the rising cases of diabetes worldwide as diabetes results in swollen feet. According to the International Diabetes Federation, around 700 million people are predicted to suffer from diabetes by 2045. Moreover, an increase in the number of diabetic patients in developing countries anticipates the demand for orthopedic footwear and diabetic footwear across the globe. The bulk of the approximately 422 million individuals with diabetes globally reside in low- and middle-income nations, and diabetes is directly responsible for 1.5 million fatalities annually.
Our in-depth analysis of the global orthopedic footwear market includes the following segments:
|
Product |
|
|
End User |
|
|
Distribution Channel |
|
|
Indication |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportOrthopedic Footwear Industry - Regional Synopsis
North American Market Forecast
The North America industry is likely to account for largest revenue share of 35% by 2037. One of the main reasons for the growth of this market in the particular region is an increase in the number of geriatric populations, as they are highly prone to numerous diseases. In addition, during this age, people usually require tailored products that are suitable to them according to their needs. Moreover, there has been a surge in the number of keyhole orthopedic surgeries, as well as a rise in the research and development for better products in countries such as the United States. There are approximately 25,500 orthopedic surgeons practicing in the United States, according to the American Academy of Orthopaedic Surgery. Also, the older population increased by 50.9 million, from 4.9 million (or 4.7% of the total U.S. population) in 1920 to 55.8 million (16.8%) in 2020. This represents a growth rate of about 1,000%, almost five times that of the total population (about 200%).
APAC Market Statistics
The orthopedic footwear market in Asia pacific is estimated to garner the second-largest revenue with a 28% share in the market. The growth of the market is anticipated to increase because of the developing healthcare infrastructure. Moreover, there has been an increasing investment by key players in the manufacturing of orthopedic footwear. In this region, people are opting for regular check-ups in order to keep themselves fit in different stages of life.
Companies Dominating the Orthopedic Footwear Landscape
- Darco
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Dr. Comfort
- Mephisto
- Apex
- Propet
- Vionic
- Chaneco
- Duna
- Orthofeet Inc.
- Piedro
In the News
- Orthofeet, Inc. ("Orthofeet"), a leading designer and manufacturer of biomechanically designed footwear, announced the launch of its first direct-to-consumer website – www.orthofeet.com. The new website, a re-design of its existing health care provider website, offers a convenient, secure way to browse and purchase a wide variety of therapeutic shoes for men and women. The site also features educational resources about foot care, with customized content for adults with diabetes who are prone to medical foot conditions.
- Mephisto launches its Nature is Future collection worldwide. At the latest edition of Micam, held from Sept. 18 to 20 in Milan for the presentation of spring/summer 2023 collections, Mephisto started distributing worldwide its sustainable women and men’s sneakers brand Nature is Future by Mephisto.
Author Credits: Radhika Pawar
- Report ID: 2508
- Published Date: Dec 20, 2024
- Report Format: PDF, PPT
